THURSDAY, Feb. 8, 2018 — Two cancer drugs can stall the progression of a particularly hard-to-treat form of prostate cancer, a pair of new trials shows.
Both a newly developed drug called apalutamide and an already approved drug called enzalutamide…Original Article
Two Drugs Offer Hope Against a Tough-to-Treat Prostate Cancer
